Leading diabetes researcher explains advances in care and studies

July 1, 2014
Leading diabetes researcher explains advances in care and studies

With worldwide rates of childhood diabetes on the rise—patient numbers double every 20 years—the race is on to discover a vaccine or possibly a special diet to stem the disease.

Dr. Marian Rewers, MD, Ph.D., professor of pediatrics and clinical director of the Barbara Davis Center for Childhood Diabetes at the Anschutz Medical Campus, spoke about advances in diabetes research during a Spotlight: Health segment of the Aspen Ideas Festival last week. Rewers and many other Anschutz Medical Campus colleagues were prominently featured during Spotlight: Health, giving a prestigious platform on which to raise the profile of the groundbreaking research and transformative health care occurring at the Anschutz Medical Campus.

Rewers, one of the nation's leading clinical researchers of diabetes, explained that environmental factors are the main cause of type 1 diabetes. "We've seen in the past 50, 60 years this relentless epidemic of childhood diabetes," he said. "Wherever you go—Europe, the U.S.—you see the same pattern. Every 20 years there are twice as many kids diagnosed with type 1 diabetes, so it cannot be caused by any genetic shifts. It has to be something coming out of the environment. ... In addition, it has to come at a vulnerable time—probably in the first year of life."

Rewers is the principal investigator of large National Institutes of Health-funded prospective cohort studies. He is heading the Colorado center as well as co-chairing the steering committee of The Environmental Determinants of Diabetes in the Young (TEDDY) study.

"We've screened almost half a million newborns in four countries—the United States and in Europe—and we're following 8,000 of those who are at very high risk for 15 years to find those elusive ," he said. "This will hopefully lead to the development of a vaccine or special diet and, ultimately, the prevention of childhood diabetes."

Rewers also discussed the rapid increase in type 2 diabetes, including in the United States, where one in three Americans born in the year 2000 will develop the disease. Worldwide, 366 million people have type 2 diabetes, and that number will increase to 552 million by 2030 (51 percent increase). The United States is forecast to see a 36 percent increase in type 2 diabetes cases over the next 20 years, he said.

Rewers pointed out that a mountain climber named Andrew Hamilton, who, as the Aspen Ideas Festival was taking place, planned to climb all of Colorado's 14,000-foot-plus peaks in just 10 days. "I'm positive he won't develop diabetes," he said. "If we just expended as much energy as we're eating every day we wouldn't have a problem."

The audience had many questions for Rewers, including this one from Lilly Marks, University of Colorado vice president for health affairs and executive vice chancellor of the Anschutz Medical Campus: Are the new drugs being developed to treat making measurable differences in health outcomes or are they just raising the cost of drugs?

"The latter," Rewers said. In the United States, pressure from individuals and patient advocacy groups is so tremendous that "drugs that should not be on the formularies are added just for the sake of trying something new. They may lower a patient's A1c levels (standard measure of glycemia in the blood), but just by 0.5 percent. It's not sufficient. You need to lower A1c by 2 percentage points," he said. "None of these drugs, or in combination, have been shown to do that."

He noted that some of the world's best care for as well as research into the disease takes place at the Anschutz Medical Campus. The Barbara Davis Center for Childhood Diabetes is "considered the No. 1 center in the world for type 1 ." In addition, the Anschutz Health and Wellness Center and the NIH-funded Center for Human Nutrition, headed by James O. Hill, Ph.D., are "doing amazing things," Rewers said, in terms of obesity research as well as the promotion of healthy living.

Explore further: Diabetes Association sets new A1C target for children with type 1 diabetes

Related Stories

Diabetes Association sets new A1C target for children with type 1 diabetes

June 16, 2014
According to a new position statement released at the Association's 74th Scientific Sessions, the American Diabetes Association is lowering its target recommendation for blood glucose levels for children with type 1 diabetes, ...

U.S. diabetes cases jump to 29 million: CDC

June 10, 2014
(HealthDay)—The number of Americans with diabetes rose from 26 million in 2010 to 29 million—9 percent of the population—in 2012, a new federal government study finds.

Burden of diabetic ketoacidosis still unacceptably high

March 31, 2014
Diabetic ketoacidosis (DKA), a life-threatening but preventable condition, remains an important problem for youth with diabetes and their families. Diabetic ketoacidosis is due to a severe lack of insulin and it is often ...

Long-term follow-up after bariatric surgery shows greater rate of diabetes remission

June 10, 2014
In a study that included long-term follow-up of obese patients with type 2 diabetes, bariatric surgery was associated with more frequent diabetes remission and fewer complications than patients who received usual care, according ...

No correlation between baby formulas and development of diabetes-associated autoantibodies

June 16, 2014
There is no correlation between the consumption of a cow's milk-based formula or hydrolyzed protein formula and the development of diabetes-associated autoantibodies in children younger than seven, according to a worldwide ...

Sleeve gastrectomy surgery improves diabetes control better than medical care

June 23, 2014
Adults with Type 2 diabetes achieve better blood glucose (sugar) control two years after undergoing laparoscopic sleeve gastrectomy than do patients who receive standard medical diabetes care without this weight loss surgery, ...

Recommended for you

In a nutshell: Walnuts activate brain region involved in appetite control

August 17, 2017
Packed with nutrients linked to better health, walnuts are also thought to discourage overeating by promoting feelings of fullness. Now, in a new brain imaging study, researchers at Beth Israel Deaconess Medical Center (BIDMC) ...

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

Pioneering immunotherapy shows promise in type 1 diabetes

August 9, 2017
It may be possible to 'retrain' the immune system to slow the progression of type 1 diabetes, according to results of a clinical trial published today in the journal Science Translational Medicine.

Online team-based game helps patients with diabetes lower blood glucose

August 8, 2017
Researchers from Brigham and Women's Hospital and the Veterans Affairs Boston Healthcare System have found that an online, team-based game designed to teach patients about diabetes self-management had a sustained and meaningful ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.